C361-0830 Screening compound: 1-cyclopropanecarbonyl-N-[3-(piperidin-1-yl)propyl]-2,3-dihydro-1H-indole-5-sulfonamide

C361-0830 Screening compound: 1-cyclopropanecarbonyl-N-[3-(piperidin-1-yl)propyl]-2,3-dihydro-1H-indole-5-sulfonamide
C361-0830 Screening compound: 1-cyclopropanecarbonyl-N-[3-(piperidin-1-yl)propyl]-2,3-dihydro-1H-indole-5-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C361-0830
1-cyclopropanecarbonyl-N-[3-(piperidin-1-yl)propyl]-2,3-dihydro-1H-indole-5-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C361-0830

Molecular Formula

C20H29N3O3S (C20 H29 N3 O3 S)

Compound Name

1-cyclopropanecarbonyl-N-[3-(piperidin-1-yl)propyl]-2,3-dihydro-1H-indole-5-sulfonamide

IUPAC name

1-cyclopropanecarbonyl-N-[3-(piperidin-1-yl)propyl]-23-dihydro-1H-indole-5-sulfonamide

SMILES

O=C(C1CC1)N(CC1)c(cc2)c1cc2S(NCCCN1CCCCC1)(=O)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

391.53

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.512

Distribution Coefficient, logD

0.327

Water Solubility, LogSw

-2.95

Polar Surface Area

62.023

Acid Dissociation Constant (pKa)

11.18

Base Dissociation Constant (pKb)

9.58

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

65.00

C361-0830 in Drug Discovery

Included in Screening Libraries

CNS targets activity set (6557 compounds)

Dark Chemical Matter Library (18430 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Structure:
  • Pool
Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C361-0830 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C361-0830?
Check Price and Availability of C361-0830, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C361-0830 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C361-0830
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C361-0830
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C361-0830 available by request